Everything NICE has said on investigating and managing dyspepsia and gastro-oesophageal reflux disease in an interactive flowchart
Working examples of quality improvement in health and social care services. Quality improvement, efficiency changes, cost savings, good practice, shared learning.
NICE transparency of spend
NICE quality improvement resource (QIR) for adult social care
Advice from NICE to help you generate evidence to inform future NICE evaluations and to enable market access
This guideline covers investigating and managing gastro-oesophageal reflux disease (GORD) and dyspepsia in people aged 18 and over. It aims to improve the treatment of GORD and dyspepsia by making detailed recommendations on Helicobacter pylori eradication, and specifying when to consider laparoscopic fundoplication and referral to specialist services.
NICE: selecting and prioritising quality standard topics.
Take an active role in producing a NICE guideline or quality standard.
Evidence-based recommendations on rivaroxaban (Xarelto) for preventing atherothrombotic events in adults with coronary or peripheral artery disease
Please complete all the required fields before submitting the form. Sign up to receive email updates on interventional
Evidence-based recommendations on lanadelumab (Takhzyro) for preventing recurrent attacks of hereditary angioedema in people aged 12 and over
Evidence-based recommendations on midcarpal hemiarthroplasty (using a metal implant to create an artificial wrist joint) for wrist arthritis in adults
NICE board strategy meeting papers
Everything NICE has said on assessing and managing recent suspected cardiac chest pain including acute coronary syndromes and stable angina in an interactive flowchart
Everything NICE has said on diagnosing and managing lower limb peripheral arterial disease in an interactive flowchart
Everything NICE has said on cardiac rehabilitation and preventing cardiovascular disease after myocardial infarction in an interactive flowchart
Information for developers of digital therapies about submitting a product to the IAPT programme
This guideline covers organising and delivering end of life care services, which provide care and support in the final weeks and months of life (or for some conditions, years), and the planning and preparation for this. It aims to ensure that people have access to the care that they want and need in all care settings. It also includes advice on services for carers.
Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart
Everything NICE has said on the care and management of osteoarthritis in adults in an interactive flowchart
Everything NICE has said on blood and immune system conditions in an interactive flowchart
Everything NICE has said about the care of people with a progressive life-limiting condition who are at the end of their life in an interactive flowchart
Everything NICE has said on triage, assessment, investigation and management of head injury in infants, children and adults in an interactive flowchart
Everything NICE has said on managing violence in mental health, health and community settings in an interactive flowchart
This guidance evaluates new, innovative medical devices and diagnostics. It looks at medical technologies that: deliver treatment - like those...
Advice on the use of superDimension Navigation System to help diagnostic sampling of peripheral lung lesions to aid local decision making
Advice on the use of MR-proADM test for use with clinical deterioration scores in cases of suspected infection to aid local decision making
An ovarian cancer treatment, designed to help maintain the effects of chemotherapy, has been approved by NICE for use in the Cancer Drugs Fund (CDF).
This guideline covers preventing and managing foot problems in children, young people and adults with diabetes. It aims to reduce variation in practice, including antibiotic prescribing for diabetic foot infections.
Everything NICE has said on preventing and managing foot problems in children, young people and adults with type 1 or 2 diabetes in an interactive flowchart
Everything NICE has said on harmful sexual behaviour among children and young people (under 18s or under 25s with special educational needs or a disability) in an interactive flowchart.
This guideline covers diagnosing and managing gastro-oesophageal reflux disease in children and young people (under 18s). It aims to raise awareness of symptoms that need investigating and treating, and to reassure parents and carers that regurgitation is common in infants under 1 year.
Evidence-based recommendations on voretigene neparvovec (Luxturna) for RPE65-mediated inherited retinal dystrophies (confirmed biallelic RPE65 gene mutations)
Evidence-based recommendations on Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea (excessive salivation and drooling) in adults
Evidence-based recommendations on the EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing
Everything NICE has said on eye conditions in an interactive flowchart
Everything NICE has said on diagnosing and managing Parkinson's disease in adults in primary and secondary care in an interactive flowchart
Everything NICE has said on assessing and managing motor neurone disease in adults in an interactive flowchart
Everything NICE has said on cerebral palsy in an interactive flowchart
NICE quality standards set out priority areas for quality improvement in health and social care.
Everything NICE has said on musculoskeletal conditions in an interactive flowchart
We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the fast track appraisal.
This guideline covers identifying and managing familial hypercholesterolaemia (FH), a specific type of high cholesterol that runs in the family, in children, young people and adults. It aims to help identify people at increased risk of coronary heart disease as a result of having FH.
Everything NICE has said on shared decision-making and processes to optimise medicines and support adherence in an interactive flowchart
Everything NICE has said on familial hypercholesterolaemia in an interactive flowchart